Olbemox, nicotinic, inhibit, K9321, K-9321, K 9321, lipolysis, Inhibitor, derivative, diabetes, antilipolytic, analogue, autonomic, Acipimox, acid, triglycerides production, tone
Acipimox is a nicotinic acid analog used as a hypolipidemic agent in research. It is particularly studied for managing hyperlipidemia in type 2 diabetic models, with applications in investigating lipid metabolism through both in vitro and in vivo experimental systems.
